Semiramis Carbajal Mamani

University of Florida

Papers

1

Total Citations

1

H-Index

1

About

Dr. Semiramis Carbajal Mamani is a dedicated researcher in gynecologic oncology, with a primary focus on optimizing perioperative care and reducing opioid dependence through Enhanced Recovery After Surgery (ERAS) protocols. Her most cited work, "Decreased Narcotic Use After the Implementation of ERAS Guidelines in Gynecologic Oncology at an Academic Center," demonstrates her commitment to evidence-based practice by evaluating how standardized pre- and post-operative care can significantly lower narcotic requirements while improving surgical outcomes, including complication rates and readmission metrics. Though her citation count is modest, her research addresses a critical need in oncologic surgery—balancing effective pain management with the risks of opioid overuse. Dr. Carbajal Mamani’s contributions are particularly valuable for clinicians and trainees seeking to implement ERAS pathways in academic settings, offering a practical framework for reducing patient exposure to narcotics. Her work underscores the importance of multidisciplinary collaboration in advancing surgical recovery, making her a key voice in the ongoing effort to refine perioperative standards in gynecologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Decreased Narcotic Use After the Implementation of ERAS Guidelines in Gynecologic Oncology at an Academic Center [24H]
1 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: University of Florida

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago